|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.185 AUD | 0.00% |
|
+8.82% | +60.87% |
| 04:00am | PharmAust Appoints Nonexecutive Chair; Shares Up 3% | MT |
| 03:09am | PharmAust Obtains Orphan Drug Designation for Monepantel; Shares Up 5% | MT |
PharmAust Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 1.92 million compared to AUD 1.68 million a year ago. Revenue was AUD 2.91 million compared to AUD 1.72 million a year ago.
Net loss was AUD 0.021184 million compared to AUD 1.23 million a year ago. Basic loss per share from continuing operations was AUD 0.0001 compared to AUD 0.0039 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +60.87% | 48.8M | |
| +32.36% | 694B | |
| +29.59% | 593B | |
| -1.60% | 371B | |
| +20.07% | 331B | |
| +6.04% | 290B | |
| +14.47% | 239B | |
| -3.56% | 209B | |
| +10.06% | 209B | |
| +9.27% | 169B |
PHARMAUST LIMITED 
